MYRIAD GENETICS, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
MYRIAD GENETICS, INC. (MYGN) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $10.28 million for the 12-month period ending 2013-06-30, per its 10-K filed 2013-08-14.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2013-08-14
- MYRIAD GENETICS, INC. foreign income tax expense (benefit), continuing operations for fiscal 2013 was $10.28M, a 99.15% increase from fiscal 2012.
- MYRIAD GENETICS, INC. foreign income tax expense (benefit), continuing operations for fiscal 2012 was $5.16M, a 1503.11% increase from fiscal 2011.
- MYRIAD GENETICS, INC. foreign income tax expense (benefit), continuing operations for fiscal 2011 was $322.00K.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2013-06-30 | $10.28M 10-K · filed 2013-08-14 |
| 2012-06-30 | $5.16M 10-K · filed 2013-08-14 |
| 2011-06-30 | $322.00K 10-K · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |